🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Creatine Supplementation During GLP-1a Therapy

RecruitingNAAges 18 Years - anyAllUniversity of Saskatchewan
NCT07625202 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

GLP-1 receptor agonists are effective for weight loss, but significant muscle mass is lost as a proportion of this weight loss. This study combines resistance-training and creatine supplementation to try to prevent this loss of muscle mass.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Starting GLP-1 agonist therapy * 18 years of age or older Exclusion Criteria: * Positive answers to a screening questionnaire for physical activity safety (the Get Active Questionnaire)
💊

What it tests

  • Dietary supplementation during a 12 week resistance-training program (creatine)
  • Dietary supplementation during a 12 week resistance-training program (placebo)
📍

Where

1 site
University of Saskatchewan
Saskatoon, Canada
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy